<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Trial Designs and Endpoints for Liver Disease Secondary to Nonalcoholic Steatohepatitis; Public Workshop</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Trial Designs and Endpoints for Liver Disease Secondary to Nonalcoholic Steatohepatitis; Public Workshop</h1>
    <p class="timestamp">Published: 2013-07-31 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research in cosponsorship with the American Association for the Study of Liver Diseases (AASLD) is announcing a 2-day public workshop entitled "Trial Designs and Endpoints for Liver Disease Secondary to Nonalcoholic fatty liver disease (NAFLD)." There are no approved treatments for NAFLD and its complications of nonalcoholic steatohepatitis (NASH) and liver fibrosis and cirrhosis. This workshop will provide a forum to disc...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-18352</p>
    <p><strong>Publication Date:</strong> 2013-07-31</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/07/31/2013-18352/trial-designs-and-endpoints-for-liver-disease-secondary-to-nonalcoholic-steatohepatitis-public">https://www.federalregister.gov/documents/2013/07/31/2013-18352/trial-designs-and-endpoints-for-liver-disease-secondary-to-nonalcoholic-steatohepatitis-public</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-18352</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
